CM
Christopher Muenzer
COO
Strides Pharma Science Limited
Social media
Is member of
Strides Pharma Science Limited
is attending
Off-Patent Semaglutide in 2026: The Next Revolution in Anti-Obesity Medications
Tuesday, October 28, 2025 12:15 PM to 12:40 PM
Hall 4.1 - 4.1J48
Aurelio Arias · IQVIA
AI: A Force for Good or a Sustainability Nightmare
Wednesday, October 29, 2025 3:00 PM to 3:45 PM
Hall 4 - 4.0G36
Sam Maguire · Clarasys
From Force Data to Function – Software for Simulating and Optimising Injector Performance
Wednesday, October 29, 2025 10:50 AM to 11:05 AM
Hall 8 - 8.0J60
Modelling to Market – Enabling Smarter, Faster Injector Development
Wednesday, October 29, 2025 11:05 AM to 11:20 AM
Hall 8 - 8.0J60
Enabling the Shift: Innovations in Primary Packaging for Large-Volume Subcutaneous Injections
Tuesday, October 28, 2025 2:00 PM to 2:25 PM
Hall 8 - 8.0J60
Isabelle Jeangoudoux · SCHOTT Pharma AG & Co. KGaA
Robert Lindner · SCHOTT Pharma AG & Co. KGaA